FR2390162A1 - Composition pharmaceutique contenant un nitro-imidazole - Google Patents

Composition pharmaceutique contenant un nitro-imidazole

Info

Publication number
FR2390162A1
FR2390162A1 FR7814291A FR7814291A FR2390162A1 FR 2390162 A1 FR2390162 A1 FR 2390162A1 FR 7814291 A FR7814291 A FR 7814291A FR 7814291 A FR7814291 A FR 7814291A FR 2390162 A1 FR2390162 A1 FR 2390162A1
Authority
FR
France
Prior art keywords
contg
hydroxybenzoic acid
hydroxybenzyl alcohol
compsns
antiprotozoal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7814291A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2390162A1 publication Critical patent/FR2390162A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a trait au domaine de la pharmacie. Elle concerne une composition pharmaceutique qui contient un médicament nitro-imidazolique en mélange avec un sel acceptable du point de vue pharmaceutique d'un acide monohydrobenzoïque ou dihydroxybenzoïque ou en mélange avec un alcool monohydroxybenzylique ou dihydroxybenzylique. Les médicaments nitro-imidazoliques tels que, par exemple, le tinidazone, sont doués de propriétés antimicrobiennes.
FR7814291A 1977-05-14 1978-05-12 Composition pharmaceutique contenant un nitro-imidazole Withdrawn FR2390162A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2037977 1977-05-14

Publications (1)

Publication Number Publication Date
FR2390162A1 true FR2390162A1 (fr) 1978-12-08

Family

ID=10144988

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814291A Withdrawn FR2390162A1 (fr) 1977-05-14 1978-05-12 Composition pharmaceutique contenant un nitro-imidazole

Country Status (16)

Country Link
JP (1) JPS542315A (fr)
AU (1) AU504551B1 (fr)
BE (1) BE867040A (fr)
DE (1) DE2820992A1 (fr)
DK (1) DK212678A (fr)
ES (1) ES469749A1 (fr)
FI (1) FI781507A (fr)
FR (1) FR2390162A1 (fr)
IL (1) IL54687A0 (fr)
IT (1) IT1115599B (fr)
LU (1) LU79655A1 (fr)
NL (1) NL7805158A (fr)
NO (1) NO781688L (fr)
PT (1) PT68034B (fr)
SE (1) SE7805471L (fr)
ZA (1) ZA782736B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024023A2 (fr) * 1979-08-11 1981-02-18 Bayer Ag Agents antimycotiques à libération plus élevée des principes actifs
FR2624736A1 (fr) * 1987-12-16 1989-06-23 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127379A (zh) * 2014-08-14 2014-11-05 珠海亿邦制药股份有限公司 一种奥硝唑注射液及其制备方法
CN110538144A (zh) * 2019-06-13 2019-12-06 南京瓦尔生物医药有限公司 一种奥硝唑注射液和s-奥硝唑注射液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE843218A (fr) * 1975-06-19 1976-12-21 Solutions injectables de metronidazole

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE843218A (fr) * 1975-06-19 1976-12-21 Solutions injectables de metronidazole

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024023A2 (fr) * 1979-08-11 1981-02-18 Bayer Ag Agents antimycotiques à libération plus élevée des principes actifs
EP0024023A3 (en) * 1979-08-11 1981-10-28 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
FR2624736A1 (fr) * 1987-12-16 1989-06-23 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole

Also Published As

Publication number Publication date
IT7823351A0 (it) 1978-05-12
NO781688L (no) 1978-11-15
NL7805158A (nl) 1978-11-16
BE867040A (fr) 1978-11-13
IT1115599B (it) 1986-02-03
PT68034B (en) 1979-10-24
LU79655A1 (fr) 1979-12-06
AU504551B1 (en) 1979-10-18
JPS542315A (en) 1979-01-09
DK212678A (da) 1978-11-15
ES469749A1 (es) 1978-12-16
ZA782736B (en) 1979-05-30
DE2820992A1 (de) 1978-12-07
IL54687A0 (en) 1978-07-31
SE7805471L (sv) 1978-11-15
PT68034A (en) 1978-06-01
FI781507A (fi) 1978-11-15

Similar Documents

Publication Publication Date Title
GB1309588A (en) Antibiotics and a process for the manufacture thereof
FR2390162A1 (fr) Composition pharmaceutique contenant un nitro-imidazole
NO157619C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksom n,n-dim-ethylglycinester av 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazol og syreaddisjonssalter derav.
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
GB1339053A (en) Method for the preparation of aromatic a-amino acids and intermediates therefor
GB1332697A (en) Benzodiazepine derivatives
ES293930A1 (es) Un procedimiento para la preparaciën de penicilinas
FR2132632A1 (en) Prepn of 2-aminomethyl imidazole derivs - hypotensives mao inhibitors anticonvulsant s, antiphlogistics, choleretics and ant
IE35335B1 (en) Medicines for treating dopamine deficiency
ES2055744T3 (es) Empleo de un quelato metalico del acido etanolaminofosforico para profilaxis y terapia.
GB1400851A (en) Triidothyroalkyl compounds their method of preparation and therapeutical compositions containing such compounds
SU137233A1 (ru) Способ лечени гнойничковых заболеваний и некоторых болезней зубов микробной этиологии
GB1317234A (en) Method of inhibiting the hydrolysis of acetylsalicyclic acid and d-propyxyphene hydrochloride
FR2336130A1 (fr) Composes utilisables dans le traitement des infections bacteriennes
ES483463A1 (es) Procedimiento de preparacion de los esteres del 1-metil-4- piperidinol
FR2054503A1 (en) 1, 4-dihydro-4-oxo quinolyl-3-carboxylic aci
IT1051732B (it) Forme diastereoisomere dell acido alfa idrazinofenil acetamido penicillanico e processo per la loro preparazione
FR2166620A5 (en) 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
IE33581B1 (en) Method of treatment and pharmaceutical preparation
ES378361A1 (es) Un procedimiento para la preparacion de derivados imidazo- lil.
FR2408304A1 (fr) Composition a base d'un amide tertiaire et d'un acide halogenethylphosphonique et son application au traitement de cotonniers
FR2085650A1 (en) 2-aza-6-(5-tetrazolyl) diphenylamines - by treating 2-anilino-3-cyano with hydrazoic acid
ES383529A1 (es) Procedimiento para la preparacion de 5-aril-3h-1,2,4-ditia-zoles.
FR2197573A1 (en) 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
FR2166623A5 (en) 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci

Legal Events

Date Code Title Description
ST Notification of lapse